相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Discovery of a Highly Selective and H435R-Sensitive ThyroidHormone Receptor?Agonist
Qiu Li et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Activation of thyroid hormone receptor-β improved disease activity and metabolism independent of body weight in a mouse model of non-alcoholic steatohepatitis and fibrosis
Aimo Kannt et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
Design, synthesis and biological evaluation of novel TRβ selective agonists sustained by ADME-toxicity analysis
Massimiliano Runfola et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
An AMPK-caspase-6 axis controls liver damage in nonalcoholic steatohepatitis
Peng Zhao et al.
SCIENCE (2020)
Selective thyroid hormone receptor β agonists with oxadiazolone acid isosteres
Thorsten A. Kirschberg et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)
Regulation of gene transcription by thyroid hormone receptor β agonists in clinical development for the treatment of non-alcoholic steatohepatitis (NASH)
Xuan G. Luong et al.
PLOS ONE (2020)
Nonalcoholic Fatty Liver Disease and Hypercholesterolemia: Roles of Thyroid Hormones, Metabolites, and Agonists
Rohit A. Sinha et al.
THYROID (2019)
Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease
Laurent Castera et al.
GASTROENTEROLOGY (2019)
Non-alcoholic fatty liver disease - A global public health perspective
Zobair M. Younossi
JOURNAL OF HEPATOLOGY (2019)
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
Naga Chalasani et al.
HEPATOLOGY (2018)
Direct effects of thyroid hormones on hepatic lipid metabolism
Rohit A. Sinha et al.
NATURE REVIEWS ENDOCRINOLOGY (2018)
Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans Is Associated With Nonalcoholic Fatty Liver Disease
Sahil Mittal et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
Design and synthesis of a novel series of [1-(4-hydroxy-benzyl)-1H-indol-5-yloxy]-acetic acid compounds as potent, selective, thyroid hormone receptor β agonists
Timothy P. Burkholder et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Discovery of 2-[3,5-Dichloro-4-(5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yloxy)phenyl]-3,5-dioxo-2,3,4,5-tetrahydro[1,2,4]triazine-6-carbonitrile (MGL-3196), a Highly Selective Thyroid Hormone Receptor β Agonist in Clinical Trials for the Treatment of Dyslipidemia
Martha J. Kelly et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
A long noncoding RNA protects the heart from pathological hypertrophy
Pei Han et al.
NATURE (2014)
Establishment of a General NAFLD Scoring System for Rodent Models and Comparison to Human Liver Pathology
Wen Liang et al.
PLOS ONE (2014)
Selective Thyromimetics Using Receptor and Tissue Selectivity Approaches: Prospects for Dyslipidemia
Amit A. Joharapurkar et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Nonalcoholic Fatty Liver Disease (NAFLD) Activity Score and the Histopathologic Diagnosis in NAFLD: Distinct Clinicopathologic Meanings
Elizabeth M. Brunt et al.
HEPATOLOGY (2011)
Chromatin regulation by Brg1 underlies heart muscle development and disease
Calvin T. Hang et al.
NATURE (2010)
Thyroid hormone mimetics: potential applications in atherosclerosis, obesity and type 2 diabetes
John D. Baxter et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Preclinical Pharmacokinetics of a HepDirect Prodrug of a Novel Phosphonate-Containing Thyroid Hormone Receptor Agonist
James M. Fujitaki et al.
DRUG METABOLISM AND DISPOSITION (2008)
Synthesis and Biological Evaluation of a Series of Liver-Selective Phosphonic Acid Thyroid Hormone Receptor Agonists and Their Prodrugs
Serge H. Boyer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
The thyroid hormone mimetic compound KB2115 lowers plasma LDL cholesterol and stimulates bile acid synthesis without cardiac effects in humans
Anders Berkenstam et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Thyroid hormone receptor subtype-β-selective agonists as potential treatments for metabolic syndrome
Gary J. Grover et al.
FUTURE LIPIDOLOGY (2007)
Targeting thyroid hormone receptor-β agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index
Mark D. Erion et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Structural rearrangements in the thyroid hormone receptor hinge domain and their putative role in the receptor function
Alessandro S. Nascimento et al.
JOURNAL OF MOLECULAR BIOLOGY (2006)
Effects of the thyroid hormone receptor agonist GC-1 on metabolic rate and cholesterol in rats and primates:: Selective actions relative to 3,5,3′-triiodo-L-thyronine
GJ Grover et al.
ENDOCRINOLOGY (2004)
Ligand selectivity by seeking hydrophobicity in thyroid hormone receptor
S Borngraeber et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Selective thyroid hormone receptor-β activation:: A strategy for reduction of weight, cholesterol, and lipoprotein (a) with reduced cardiovascular liability
GJ Grover et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Discovery of a novel series of 6-azauracil-based thyroid hormone receptor ligands:: Potent, TRβ subtype-selective thyromimetics
RL Dow et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
Clinical and experimental studies on the use of 3,5-diiodothyropropionic acid, a thyroid hormone analogue, in heart failure
E Morkin et al.
THYROID (2002)
分享论文
